You just read:

Profectus BioSciences Receives $9.5 Million Department of Defense Funding to Manufacture Trivalent VesiculoVax™-Vectored Vaccine to Protect Against all Ebola and Marburg Viruses

News provided by

Profectus BioSciences, Inc.

Oct 31, 2014, 08:00 ET